🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12554+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12554 recruiting trials

Phase 1RecruitingNCT05030298

Preoperative Radiosurgery for the Treatment of High Grade Glioma, NeoGlioma Trial

👨‍⚕️ Daniel M. Trifiletti, MD, Mayo Clinic📍 2 sites📅 Started May 2023View details ↗
Phase 1RecruitingNCT05868174

Combination of 177Lu-TLX250 and Peposertib in Patients With Carbonic Anhydrase IX -Expressing Solid Tumors

🏥 Telix Pharmaceuticals (Innovations) Pty Limited📍 5 sites📅 Started May 2023View details ↗
Phase 1RecruitingNCT05942625

A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10390 in Healthy Subjects

🏥 Hansoh BioMedical R&D Company📍 1 site📅 Started May 2023View details ↗
NARecruitingNCT05791162

Interest of Follicular Helper Lymphocytes / Regulatory Follicular Helper Lymphocytes Ratio in IgA Nephropathy

👨‍⚕️ Melchior Chabannes, MD, Nephrology, CHU Besançon📍 1 site📅 Started May 2023View details ↗
Phase 1, PHASE2RecruitingNCT05919264

FOG-001 in Locally Advanced or Metastatic Solid Tumors

👨‍⚕️ Jorge Ramos, DO, Parabilis Medicines, Inc.📍 23 sites📅 Started May 2023View details ↗
NARecruitingNCT05917678

Effectiveness of Repositioning and Cranial Remolding in Infants With Cranial Deformation

👨‍⚕️ Tiffany Graham, University of Texas Southwestern Medical Center📍 1 site📅 Started May 2023View details ↗
Phase 1RecruitingNCT05794958

Evaluate Safety of Axicabtagene Ciloleucel Reinfusion (Axi-Cel-2) in Patients With Relapsed and/or Refractory Second Line High-Risk Non-Hodgkin Lymphoma After Standard of Care Axi-Cel

👨‍⚕️ Saurabh Dahiya, MD, Stanford University📍 1 site📅 Started May 2023View details ↗
NARecruitingNCT06946498

First Local Anaesthesia Thoracoscopy for Pleural Effusion Diagnosis.

👨‍⚕️ Grigorios Stratakos, Professor, National and Kapodistrian University of Athens📍 1 site📅 Started May 2023View details ↗
NARecruitingNCT05310799

Personalized Estimates of Response and Severity Outcomes in Newly-diagnosed JIA

👨‍⚕️ Lori B Tucker, MD, University of British Columbia Department of Pediatrics📍 1 site📅 Started May 2023View details ↗
Phase 2RecruitingNCT05619913

EPOCH: Eribulin and Pembrolizumab in Ovarian/Uterine Carcinosarcoma

👨‍⚕️ Clare Scott, AM MB BS PhD, Peter MacCallum Cancer Centre, Australia📍 6 sites📅 Started May 2023View details ↗
RecruitingNCT06111833

Optimized Diagnosis and Precision Medicine of MODY

👨‍⚕️ Yi-Jing Sheen, MD. PHD, Division of Endocrinology and Metabolism in Taichung Veterans General Hospital📍 1 site📅 Started May 2023View details ↗
Phase 1RecruitingNCT04972942

Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA with High Risk T-Cell ALL & Lymphoma

👨‍⚕️ Mitchell Cairo, MD, New York Medical College📍 16 sites📅 Started May 2023View details ↗
Phase 4RecruitingNCT05849740

An Exploratory Study of Cluster of Differentiation 38 (CD38) Monoclonal Antibody Combined Corticosteroid in Acquired Hemophilia A

👨‍⚕️ Lei Zhang, Chinese Academy of Medical Science and Blood Disease Hospital📍 1 site📅 Started May 2023View details ↗
NARecruitingNCT06307171

Human Leishmaniasis: Antigen Recognition Pattern and Study of New Potential Biomarkers

🏥 IRCCS Sacro Cuore Don Calabria di Negrar📍 1 site📅 Started May 2023View details ↗
Phase 2RecruitingNCT05737121

Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS

🏥 Vaneltix Pharma, Inc.📍 14 sites📅 Started May 2023View details ↗
Phase 2RecruitingNCT05884333

Cord Blood Transplant in Adults With Blood Cancers

👨‍⚕️ Ann Jakubowski, MD, Memorial Sloan Kettering Cancer Center📍 1 site📅 Started May 2023View details ↗
RecruitingNCT05922397

Placenta Accreta Spectrum Topographic Classification

👨‍⚕️ Albaro J Nieto-Calvache, MD, Fundacion Clinica Valle del Lili📍 1 site📅 Started May 2023View details ↗
NARecruitingNCT06775561

Precision Diagnosis and Therapy for Rare Diseases by Interpreting Non-coding Genomes

👨‍⚕️ Tommaso Pippucci, Biologist, IRCCS Azienda Ospedaliero-Universitaria di Bologna📍 1 site📅 Started May 2023View details ↗
NARecruitingNCT05857891

The Effect of Erythropoietin on Alveolar Fluid Clearance in Patients With Acute Respiratory Distress Syndrome

👨‍⚕️ Ye Gao, PhD, Second Affiliated Hospital of Wenzhou Medical University📍 1 site📅 Started May 2023View details ↗
RecruitingNCT06917924

A Patient-tailored Genetic/Biomarker/iPSC Combined Approach in ALS - PERMEALS

🏥 A.O.U. Città della Salute e della Scienza📍 4 sites📅 Started May 2023View details ↗
← PreviousPage 406 of 628Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →